首页>
外文期刊>Gynecologic Oncology Reports
>Impact of lower uterine segment involvement in type II endometrial cancer and the unique mutational profile of serous tumors
【24h】
Impact of lower uterine segment involvement in type II endometrial cancer and the unique mutational profile of serous tumors
Objective Evaluation of the impact of lower uterine segment involvement (LUSI) in type II endometrial cancer, and mutational profile of uterine papillary serous carcinomas (UPSC). Methods Retrospective cohort study comparing patients with type II endometrial cancer with LUSI to patients without LUSI. Genes commonly implicated in carcinogenesis were analyzed in a subgroup of 42 patients with UPSC using next generation sequencing. Results 83 patients with type II endometrial cancer were included in the study, of these, LUSI was diagnosed in 31.3%. During a median follow-up of 45.5?months, patients with LUSI developed more local and distant recurrences (local: 19.2% vs. 3.5%, P ?=?.03; distant: 50% vs. 17.5%, P ?=?.004) and progression events (73.1% vs. 26.3%, P ?.001), with shorter mean progression-free survival (16?months compared to 26.5?months, P ?.01). In a multivariate analysis, LUSI was the only significant pathological factor, associated with a 2.9-fold increase in the risk of progression ( P ?=?.007), and a 2.6-fold increase in the risk of death ( P ?=?.02). In the subgroup of patients with UPSC, mutations were identified in 54 genes, including TP53 (80%), PPP2R1A (40%), and PTEN (22.5%). Frequent mutations in the PTEN-PI3K-AKT signaling pathway were found in patients with tumor in the upper uterine segment only ( P ?=?.04), with PTEN being mutated in 29% of the samples ( P ?=?.07). Conclusion Type II endometrial cancers presenting in the LUS have a significantly worse prognosis and this might be associated with a unique mutational profile. Highlights ? Lower uterine segment involvement is common in type II endometrial cancer. ? Type II tumors in the lower uterine segment are associated with adverse outcome. ? Serous type lower uterine segment tumors mapped with a unique mutational profile.
展开▼